ArthritisResTher
@arthritisres
Arthritis Research & Therapy is an international open access journal that publishes articles on arthritis and related autoimmune conditions.
ID: 423349335
http://arthritis-research.biomedcentral.com/ 28-11-2011 11:45:20
904 Tweet
3,3K Followers
1,1K Following
News: Considering baseline obesity could improve chances of treat-to-target success in people with moderately active #RheumatoidArthritis, suggest study findings from Sook Yan Lee (King's College London), Elena Nikiphorou & team ArthritisResTher bit.ly/3lOmVza
We're excited to share our latest research on #cannabinoid type 2 receptor in #dermatomyositis! Important findings as we continue to investigate the effects of #Lenabasum in DM ArthritisResTher by Spandana Maddukuri, Jay Patel, DeAnna Diaz doi.org/10.1186/s13075…
Our new paper on non-criteria #antiphospholipidsyndrome, suggesting that non-criteria manifestations affect the prognosis of seronegative APS patients, with increased thrombosis recurrence.gerard espinosa Ricard Cervera Olga Araújo | MD, PhD👩🏻🎓 gatocobotas ArthritisResTher arthritis-research.biomedcentral.com/articles/10.11…
Finally out! ➡️rdcu.be/cEOw0 Never too late to confirm the safety of #CovidVaccination in #autoimmune #rheumatic diseases. Just published in ArthritisResTher our paper showing low frequency of flares and good tolerability of #mRNA vaccine. Ennio Giulio Favalli Cristina Garufi
News: Underlying comorbidities may contribute to the increased #VTE risk seen in people with #PsoriaticArthritis, research suggests ArthritisResTher bit.ly/33vgb3b
#ResearchHighlight | Neutrophils implicated in early enthesitis #Spondyloarthritis #Enthesitis Brigham and Women's Hospital Leeds Spondyloarthritis Team Read the original research from ArthritisResTher here bit.ly/3qYmIMF Read our #news story here go.nature.com/3o2cWqV
Very happy to share our paper in ArthritisResTher on non criteria manifestations in primary #antiphospholipidsyndrome which might help identify patients with a high-risk profile ! Arsene Mekinian sellam jeremie de Moreuil Claire Elalamy My Ismail Chasset F doi.org/10.1186/s13075…
JUST PUBLISHED! A systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations! doi.org/10.1186/s13075… ArthritisResTher
Beyond excited to share our paper, and a large part of my thesis work, out today in ArthritisResTher! Check out our #singlecell #transcriptomics study investigating changes in lymphatic muscle and peri-lymphatic cells in mice with inflammatory arthritis 👍🏻 arthritis-research.biomedcentral.com/articles/10.11…
It's #WorldKidneyDay!🫘 Here are #renal co-morbidity in patients with #rheumatic diseases 👉🏽arthritis-research.biomedcentral.com/articles/10.11… by Hans-Joachim Anders Volker Vielhauer ArthritisResTher #worldkidneyday2022 #rheumatology #kidney #kidneys
News: Yannick van Sleen (UMCG) and co-researchers have identified disease-specific biomarkers that may improve diagnosis of giant cell arteritis in people with #PolymyalgiaRheumatica ArthritisResTher bit.ly/3qhQuLG
We are excited to share our recent study validating galectin-3 binding protein (G3BP) as a urine #biomarker of active #lupusnephritis in ArthritisResTher. arthritis-research.biomedcentral.com/articles/10.11…
News: Alemtuzumab may warrant further investigation for refractory primary systemic #vasculitis, suggests the ALEVIATE trial from Pani Gopaluni & team Cambridge University Cambridge University Hospitals NHS ArthritisResTher bit.ly/3xkUbEx
Chris Graf explores whether peer review can keep up with what we've grown to expect from it, considers what our expectations should be, and gives us reasons to be cheerful! scholarlykitchen.sspnet.org/2022/09/20/gue… #PeerReviewWeek22 #PublicationEthics Scholarly Kitchen
What message would you like to share this #IWD2023? Read the full Q&A with Ana Lorena Ruano as the new Editor-in-Chief of Int Journal for Equity in Health and her thoughts on inequities and being a woman in science. …inabilitycommunity.springernature.com/posts/meet-the…
A biomarker panel that includes matrix metalloproteinases-degraded type III collagen and other markers may help assess #PsA flares, according to findings in ArthritisResTher by Vinod Chandran, MD, PhD, of Department of Medicine University of Toronto. Learn more here: buff.ly/3WyRdHB #SoMeDocs #MedTwitter